Pridiktiv has been acquired by Corilus
October 2020 — The shareholders and founders of Pridiktiv NV have sold the company to Corilus.
Pridiktiv specializes in mobile cloud-based healthcare solutions that turn big and raw patient data into user-friendly and actionable data to support day-to-day health/elderly care. Its into.care software is a revolutionary and comprehensive suite covering basic medical/care patient administration, work planning, medication, accounting and management reporting.
Corilus is the Belgian market leader in software and ICT solutions for elderly care. It develops smart and efficient systems and connects healthcare providers, patients and stakeholders. Corilus’ software has applications for general practitioners, pharmacists, physiotherapists, midwives and elderly homes. Corilus, a portfolio company of Gilde Buy Out Partners, has over 40,000 customers, served out of seven locations.
Our role in the transaction
Oaklins’ team in Belgium acted as the sole financial advisor to the sellers in this transaction.
Jeroen De Backer
CEO, Pridiktiv NV
Talk to the deal team
Pieter Vanhoudt
Oaklins KBC Securities
Related deals
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreGroGlass has been acquired by Apogee Enterprises
Apogee Enterprises, Inc. (Nasdaq: APOG), a leading US provider of architectural building products, services and high-performance coated materials, has acquired GroGlass, a Latvia-based developer and manufacturer of high-performance anti-reflective and UV-protective glass coatings. The acquisition brings GroGlass’ differentiated coating technologies and materials science expertise into Apogee’s performance surfaces segment, broadening its product offering and market reach while expanding its manufacturing and R&D presence in Europe.
Learn more